Proven Answers for Protein, Vaccine and Nucleotide Characterization
Each therapeutic candidate has its own unique challenges, suggesting a variety of analytical instruments may be needed to reduce risk, meet regulatory requirements, and successfully bring biologics to market.
Join Peter Holper from SCIEX to discover how a single analytical platform provides the flexibility to accurately perform a variety of analytical assays for various drug modalities, while learning about new applications for process development.
This webcast will cover IgGs and other glycoproteins as well as nucleic acids, using optical or MS detection.
Key Learning Objectives:
Get introduced to validated analytical assays for therapeutic proteins and ways to increase throughput without affecting data quality and integrity.
Discover a platform that can cover modalities ranging from proteins to vaccines to nucleic acids and more.
Learn about applications such as ion analysis and their applicability to matrix confirmation and cell culture media quantitation.